Promotional effect of microRNA-194 on breast cancer cells via targeting F-box/WD repeat-containing protein 7

  • Authors:
    • Yaomin Chen
    • Haiyan Wei
    • Yu Liu
    • Shusen Zheng
  • View Affiliations

  • Published online on: January 23, 2018     https://doi.org/10.3892/ol.2018.7842
  • Pages: 4439-4444
Metrics: HTML 0 views | PDF 0 views     Cited By (CrossRef): 0 citations

Abstract

Breast cancer is the most common type of malignant cancer in females. An increasing number of studies have revealed that microRNAs (miR), which belong to a class of small non‑coding RNAs, serve an important role in a number of human cancer subtypes. In the present study, the role of miR‑194 in breast cancer cells and its underlying mechanisms were investigated. The results demonstrated that the serum levels of miR‑194 were significantly higher in patients of the poorly differentiated and well‑differentiated groups, compared with in healthy adults. Additionally, the serum level of miR‑194 was significantly higher in the poorly differentiated group compared with in the well‑differentiated group. In order to further investigate the role of miR‑194 in breast cancer cells, the present study transfected two breast cancer cell lines, MCF‑7 and MDA‑MB‑231, with an empty vector (control), miR‑194 (overexpression), antagomiR‑194 (inhibitor, functional knock down) or antagomiR‑194 and miR‑194. An MTT assay was performed in order to detect the proliferation of breast cancer cells in the various groups. The results revealed that the overexpression of miR‑194 significantly accelerated cell proliferation, whereas the inhibition of miR‑194 significantly decelerated the proliferation of MCF‑7 and MDA‑MB‑231 cells. Furthermore, the expression levels of cyclin D and cyclin E were significantly upregulated in miR‑194 overexpressing cells, and the expression levels of cyclin D and cyclin E were significantly downregulated in miR‑194 inhibited cells, as compared with in control cells. No significant change was observed in the level of proliferation of cells co‑transfected with miR‑194 and antagomiR‑194, compared with in the control cells. According to the hypothesis suggesting possible target genes of miR‑194, the present study proposed that F‑box/WD repeat‑containing protein 7 (Fbxw‑7) may be a direct target of miR‑194, which was confirmed by a luciferase reporter assay. The present study suggested that miR‑194 expression promoted the proliferation of breast cancer cells by targeting Fbxw‑7, and may serve as a biomarker and a novel target for breast cancer therapy.

References

1 

Van Diest PJ, van der Wall E and Baak JP: Prognostic value of proliferation in invasive breast cancer: A review. J Clin Pathol. 57:675–681. 2004. View Article : Google Scholar : PubMed/NCBI

2 

Yu H, Yang J, Jiao S, Li Y, Li L and Wang J: A proliferation-inducing ligand expression in breast cancer and its relationship with prognosis. Nan Fang Yi Ke Da Xue Xue Bao. 35:185–190. 2015.(In Chinese). PubMed/NCBI

3 

Wu X, Zeng R, Wu S, Zhong J, Yang L and Xu J: Comprehensive expression analysis of miRNA in breast cancer at the miRNA and isomiR levels. Gene. 557:195–200. 2015. View Article : Google Scholar : PubMed/NCBI

4 

Xue J, Chi Y, Chen Y, Huang S, Ye X, Niu J, Wang W, Pfeffer LM, Shao ZM, Wu ZH and Wu J: MiRNA-621 sensitizes breast cancer to chemotherapy by suppressing FBXO11 and enhancing p53 activity. Oncogene. 35:448–458. 2016. View Article : Google Scholar : PubMed/NCBI

5 

Zaleska K: miRNA - Therapeutic tool in breast cancer? Where are we now? Rep Pract Oncol Radiother. 20:79–86. 2014. View Article : Google Scholar : PubMed/NCBI

6 

Fiannaca A, La Rosa M, La Paglia L, Rizzo R and Urso A: Analysis of miRNA expression profiles in breast cancer using biclustering. BMC Bioinformatics. 16 Suppl 4:S72015. View Article : Google Scholar : PubMed/NCBI

7 

McGuire A, Brown JA and Kerin MJ: Metastatic breast cancer: The potential of miRNA for diagnosis and treatment monitoring. Cancer Metastasis Rev. 34:145–155. 2015. View Article : Google Scholar : PubMed/NCBI

8 

Le XF, Almeida MI, Mao W, Spizzo R, Rossi S, Nicoloso MS, Zhang S, Wu Y, Calin GA and Bast RC Jr: Modulation of MicroRNA-194 and cell migration by HER2-targeting trastuzumab in breast cancer. PLoS One. 7:e411702012. View Article : Google Scholar : PubMed/NCBI

9 

Iizuka D, Imaoka T, Nishimura M, Kawai H, Suzuki F and Shimada Y: Aberrant microRNA expression in radiation-induced rat mammary cancer: The potential role of miR-194 overexpression in cancer cell proliferation. Radiat Res. 179:151–159. 2013. View Article : Google Scholar : PubMed/NCBI

10 

Fujii Y, Yada M, Nishiyama M, Kamura T, Takahashi H, Tsunematsu R, Susaki E, Nakagawa T, Matsumoto A and Nakayama KI: Fbxw7 contributes to tumor suppression by targeting multiple proteins for ubiquitin-dependent degradation. Cancer Sci. 97:729–736. 2006. View Article : Google Scholar : PubMed/NCBI

11 

Koepp DM, Schaefer LK, Ye X, Keyomarsi K, Chu C, Harper JW and Elledge SJ: Phosphorylation-dependent ubiquitination of cyclin E by the SCFFbw7 ubiquitin ligase. Science. 294:173–177. 2001. View Article : Google Scholar : PubMed/NCBI

12 

Moberg KH, Bell DW, Wahrer DC, Haber DA and Hariharan IK: Archipelago regulates Cyclin E levels in Drosophila and is mutated in human cancer cell lines. Nature. 413:311–316. 2001. View Article : Google Scholar : PubMed/NCBI

13 

Strohmaier H, Spruck CH, Kaiser P, Won KA, Sangfelt O and Reed SI: Human F-box protein hCdc4 targets cyclin E for proteolysis and is mutated in a breast cancer cell line. Nature. 413:316–322. 2001. View Article : Google Scholar : PubMed/NCBI

14 

Welcker M, Orian A, Jin J, Grim JE, Harper JW, Eisenman RN and Clurman BE: The Fbw7 tumor suppressor regulates glycogen synthase kinase 3 phosphorylation-dependent c-Myc protein degradation. Proc Natl Acad Sci USA. 101:pp. 9085–9090. 2004; View Article : Google Scholar : PubMed/NCBI

15 

Yada M, Hatakeyama S, Kamura T, Nishiyama M, Tsunematsu R, Imaki H, Ishida N, Okumura F, Nakayama K and Nakayama KI: Phosphorylation-dependent degradation of c-Myc is mediated by the F-box protein Fbw7. EMBO J. 23:2116–2125. 2004. View Article : Google Scholar : PubMed/NCBI

16 

Mao JH, Perez-Losada J, Wu D, Delrosario R, Tsunematsu R, Nakayama KI, Brown K, Bryson S and Balmain A: Fbxw7/Cdc4 is a p53-dependent, haploinsufficient tumour suppressor gene. Nature. 432:775–779. 2004. View Article : Google Scholar : PubMed/NCBI

17 

Hubbard EJ, Wu G, Kitajewski J and Greenwald I: sel-10, a negative regulator of lin-12 activity in Caenorhabditis elegans, encodes a member of the CDC4 family of proteins. Genes Dev. 11:3182–3193. 1997. View Article : Google Scholar : PubMed/NCBI

18 

Gupta-Rossi N, Le Bail O, Gonen H, Brou C, Logeat F, Six E, Ciechanover A and Israël A: Functional interaction between SEL-10, an F-box protein, and the nuclear form of activated Notch1 receptor. J Biol Chem. 276:34371–34378. 2001. View Article : Google Scholar : PubMed/NCBI

19 

Oberg C, Li J, Pauley A, Wolf E, Gurney M and Lendahl U: The Notch intracellular domain is ubiquitinated and negatively regulated by the mammalian Sel-10 homolog. J Biol Chem. 276:35847–35853. 2001. View Article : Google Scholar : PubMed/NCBI

20 

Wu G, Lyapina S, Das I, Li J, Gurney M, Pauley A, Chui I, Deshaies RJ and Kitajewski J: SEL-10 is an inhibitor of notch signaling that targets notch for ubiquitin-mediated protein degradation. Mol Cell Biol. 21:7403–7415. 2001. View Article : Google Scholar : PubMed/NCBI

21 

Nateri AS, Riera-Sans L, Da Costa C and Behrens A: The ubiquitin ligase SCFFbw7 antagonizes apoptotic JNK signaling. Science. 303:1374–1378. 2004. View Article : Google Scholar : PubMed/NCBI

22 

Balamurugan K, Wang JM, Tsai HH, Sharan S, Anver M, Leighty R and Sterneck E: The tumour suppressor C/EBPδ inhibits FBXW7 expression and promotes mammary tumour metastasis. EMBO J. 29:4106–4117. 2010. View Article : Google Scholar : PubMed/NCBI

23 

Fu L, Balasubramanian M, Shan J, Dudenhausen EE and Kilberg MS: Auto-activation of c-JUN gene by amino acid deprivation of hepatocellular carcinoma cells reveals a novel c-JUN-mediated signaling pathway. J Biol Chem. 286:36724–36738. 2011. View Article : Google Scholar : PubMed/NCBI

24 

Snijders AM, Liu Y, Su L, Huang Y and Mao JH: Expression profiling reveals transcriptional regulation by Fbxw7/mTOR pathway in radiation-induced mouse thymic lymphomas. Oncotarget. 6:44794–44805. 2015. View Article : Google Scholar : PubMed/NCBI

25 

Hernandez MA, Patel B, Hey F, Giblett S, Davis H and Pritchard C: Regulation of BRAF protein stability by a negative feedback loop involving the MEK-ERK pathway but not the FBXW7 tumour suppressor. Cell Signal. 28:561–571. 2016. View Article : Google Scholar : PubMed/NCBI

26 

Akhoondi S, Lindström L, Widschwendter M, Corcoran M, Bergh J, Spruck C, Grandér D and Sangfelt O: Inactivation of FBXW7/hCDC4-β expression by promoter hypermethylation is associated with favorable prognosis in primary breast cancer. Breast Cancer Res. 12:R1052010. View Article : Google Scholar : PubMed/NCBI

27 

Li J, Guo Y, Liang X, Sun M, Wang G, De W and Wu W: MicroRNA-223 functions as an oncogene in human gastric cancer by targeting FBXW7/hCdc4. J Cancer Res Clin Oncol. 138:763–774. 2012. View Article : Google Scholar : PubMed/NCBI

28 

Livak KJ and Schmittgen TD: Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001. View Article : Google Scholar : PubMed/NCBI

29 

Lewis BP, Shih I-H, Jones-Rhoades MW, Bartel DP and Burge CB: Prediction of mammalian microRNA targets. Cell. 115:787–798. 2003. View Article : Google Scholar : PubMed/NCBI

30 

Chen P and Yao GD: The role of cullin proteins in gastric cancer. Tumor Biol. 37:29–37. 2016. View Article : Google Scholar

31 

Wu XZ, Wang KP, Song HJ, Xia JH, Jiang Y and Wang YL: MiR-27a-3p promotes esophageal cancer cell proliferation via F-box and WD repeat domain-containing 7 (FBXW7) suppression. Int J Clin Exp Med. 8:15556–15562. 2015.PubMed/NCBI

32 

Liu SG, Qin XG, Zhao BS, Qi B, Yao WJ, Wang TY, Li HC and Wu XN: Differential expression of miRNAs in esophageal cancer tissue. Oncol Lett. 5:1639–1642. 2013. View Article : Google Scholar : PubMed/NCBI

33 

Tanić M, Yanowski K, Andrés E, Gómez-López G, Socorro MR, Pisano DG, Martinez-Delgado B and Benítez J: miRNA expression profiling of formalin-fixed paraffin-embedded (FFPE) hereditary breast tumors. Genom Data. 3:75–79. 2014. View Article : Google Scholar : PubMed/NCBI

34 

Hu J, Xu J, Wu Y, Chen Q, Zheng W, Lu X, Zhou C and Jiao D: Identification of microRNA-93 as a functional dysregulated miRNA in triple-negative breast cancer. Tumour Biol. 36:251–258. 2015. View Article : Google Scholar : PubMed/NCBI

35 

Wu Z, Wang P, Song C, Wang K, Yan R, Li J and Dai L: Evaluation of miRNA-binding-site SNPs of MRE11A, NBS1, RAD51 and RAD52 involved in HRR pathway genes and risk of breast cancer in China. Mol Genet Genomics. 290:1141–1153. 2015. View Article : Google Scholar : PubMed/NCBI

36 

Zhang W, Qian P, Zhang X, Zhang M, Wang H, Wu M, Kong X, Tan S, Ding K, Perry JK, et al: Autocrine/paracrine human growth hormone-stimulated MicroRNA 96-182-183 cluster promotes epithelial-mesenchymal transition and invasion in breast cancer. J Biol Chem. 290:13812–13829. 2015. View Article : Google Scholar : PubMed/NCBI

37 

Meng Z, Fu X, Chen X, Zeng S, Tian Y, Jove R, Xu R and Huang W: miR-194 is a marker of hepatic epithelial cells and suppresses metastasis of liver cancer cells in mice. Hepatology. 52:2148–2157. 2010. View Article : Google Scholar : PubMed/NCBI

38 

Song Y, Zhao F, Wang Z, Liu Z, Chiang Y, Xu Y, Gao P and Xu H: Inverse association between miR-194 expression and tumor invasion in gastric cancer. Ann Surg Oncol. 19 Suppl 3:S509–S517. 2012. View Article : Google Scholar : PubMed/NCBI

39 

Chen X, Wang Y, Zang W, Du Y, Li M and Zhao G: miR-194 targets RBX1 gene to modulate proliferation and migration of gastric cancer cells. Tumour Biol. 36:2393–2401. 2015. View Article : Google Scholar : PubMed/NCBI

40 

Khella HW, Bakhet M, Allo G, Jewett MA, Girgis AH, Latif A, Girgis H, Von Both I, Bjarnason GA and Yousef GM: miR-192, miR-194 and miR-215: A convergent microRNA network suppressing tumor progression in renal cell carcinoma. Carcinogenesis. 34:2231–2239. 2013. View Article : Google Scholar : PubMed/NCBI

41 

Zhang J, Zhao CY, Zhang SH, Yu DH, Chen Y, Liu QH, Shi M, Ni CR and Zhu MH: Upregulation of miR-194 contributes to tumor growth and progression in pancreatic ductal adenocarcinoma. Oncol Rep. 31:1157–1164. 2014. View Article : Google Scholar : PubMed/NCBI

42 

Yokobori T, Mimori K, Iwatsuki M, Ishii H, Onoyama I, Fukagawa T, Kuwano H, Nakayama KI and Mori M: p53-Altered FBXW7 expression determines poor prognosis in gastric cancer cases. Cancer Res. 69:3788–3794. 2009. View Article : Google Scholar : PubMed/NCBI

43 

Iwatsuki M, Mimori K, Ishii H, Yokobori T, Takatsuno Y, Sato T, Toh H, Onoyama I, Nakayama KI, Baba H and Mori M: Loss of FBXW7, a cell cycle regulating gene, in colorectal cancer: Clinical significance. Int J Cancer. 126:1828–1837. 2010.PubMed/NCBI

Related Articles

Journal Cover

April 2018
Volume 15 Issue 4

Print ISSN: 1792-1074
Online ISSN:1792-1082

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
APA
Chen, Y., Wei, H., Liu, Y., & Zheng, S. (2018). Promotional effect of microRNA-194 on breast cancer cells via targeting F-box/WD repeat-containing protein 7. Oncology Letters, 15, 4439-4444. https://doi.org/10.3892/ol.2018.7842
MLA
Chen, Y., Wei, H., Liu, Y., Zheng, S."Promotional effect of microRNA-194 on breast cancer cells via targeting F-box/WD repeat-containing protein 7". Oncology Letters 15.4 (2018): 4439-4444.
Chicago
Chen, Y., Wei, H., Liu, Y., Zheng, S."Promotional effect of microRNA-194 on breast cancer cells via targeting F-box/WD repeat-containing protein 7". Oncology Letters 15, no. 4 (2018): 4439-4444. https://doi.org/10.3892/ol.2018.7842